CG Oncology, Inc. Common stock
← Back to CGON Overview

CG Oncology, Inc. Common stock (CGON)

Earnings & Profitability History

Latest EPS

$-0.52

Net Income

-41309000

Financial Fundamentals

CGONQuarterly Data • 5Y View

Historical Data Table

Quarterly Net Income & EPS

DateNet Income ($B)NI YoY %TTM NIEPSEPS YoY %TTM EPS
2025-12-31-0.04-29.9%-0.16-0.52-6.1%-2.08
2025-09-30-0.04-114.7%-0.15-0.57-90.0%-2.05
2025-06-30-0.04-119.2%-0.13-0.54-92.9%-1.78
2025-03-31-0.03-103.5%-0.11-0.45-80.0%-1.52
2024-12-31-0.03-97.3%-0.09-0.49-48.5%-1.32
2024-09-30-0.02-73.4%-0.07-0.30-7.1%-1.16
2024-06-30-0.02-62.8%-0.06-0.28-64.7%-1.14
2024-03-31-0.02-95.4%-0.06-0.25-92.3%-1.03
2023-12-31-0.02-92.0%-0.05-0.33-153.8%-0.91
2023-09-30-0.01-0.04-0.28-0.71
2023-06-30-0.01-0.17
2023-03-31-0.01-0.13
2022-12-31-0.01-0.13

Annual Performance

YearNet Income ($B)Growth %EPSEPS Growth %
2025-0.16-82.9%-2.08-47.5%
2024-0.09-81.1%-1.41-38.2%
2023-0.05-37.1%-1.02-54.5%
2022-0.04-176.1%-0.66-135.7%
2021-0.01-0.28